The results suggested that higher PRDX2 expression was significantly correlated with worse OS (P < 0.001), in 1925 lung cancer patients (967 samples with low PRDX2 expression and 958 samples with high PRDX2 expression) (Figure 1(a)). The gene discussed is PRDX2; the disease is lung cancer.